Prescribing Hope and Restoring Balance
ExesaLibero Pharma is a development-stage biopharmaceutical company developing small-molecule drugs targeting bone erosion in diseases such as rheumatoid arthritis, multiple myeloma, and periodontal disease. The company's lead candidate ELP-004 is advancing through preclinical toxicology and efficacy studies, with partnerships with West Virginia University, the University of Kansas, and the University of Pittsburgh. ExesaLibero operates out of WVU's Innovation Corporation facility in Morgantown, West Virginia.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNo funding data available yet.
Know something? Help us improve our data.
Create a free account to see which investors have funded this company.
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Food technology company creating plant-based meat and dairy products that replicate the taste and...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
